Arginine supplementation curbs Alzheimer's disease pathology in animal models

Alzheimer's disease (AD), a progressive neurodegenerative disorder, is one of the leading causes of dementia worldwide, and currently has no definitive cure. Although antibody-based therapies that ...
Voice&Data

Scientists use AI model to decode protein-to-protein ‘talk’

The AI model in news offers deeper insight into protein-to-protein talk, advancing innovation in understanding mutations, ...
Hosted on MSN

Larimar Therapeutics Shows Promise in Friedreich’s Ataxia Treatment

Larimar Therapeutics, Inc. ( (LRMR)) has released its Q3 earnings. Here is a breakdown of the information Larimar Therapeutics, Inc. presented to its investors. Larimar Therapeutics, Inc. is a ...
Healio

Q&A: Advocates meet with lawmakers in support of patients with Friedreich’s ataxia

Please provide your email address to receive an email when new articles are posted on . Approximately 5,000 people in the United States have Friedreich’s ataxia. Advocates virtually met with ...
Baylor College of Medicine

Researchers restore fertility in mouse model of non-obstructive azoospermia

An international research team led by Baylor College of Medicine and The University of Osaka have found a way to resume sperm production, leading to healthy offspring in mouse models with ...
MarketWatch

Lexeo Shares Rise On Progress for Heart Disease Treatment

Shares of Lexeo Therapeutics rose in off-hours trading after the company reported progress in discussions with the Food and Drug Administration regarding the accelerated approval pathway for its ...
BioWorld

Lexeo, FDA position Friedreich ataxia therapy for accelerated path

Lexeo Therapeutics Inc. feels like it’s in a faster lane to a BLA for its Friedreich ataxia cardiomyopathy gene therapy after talking with the U.S. FDA. The agency told Lexeo that LX-2006 could be on ...
FiercePharma

Biogen supports Friedreich's ataxia web series to get Bill Nye back in the lab

With cries of “Bill! Bill! Bill!” still echoing from the ’90s, Biogen has signed on to a partnership that’s getting Bill Nye back in the lab. The beloved television presenter is now starring in a four ...
The Business Journals

Larimar Therapeutics' stock price tumbles on mixed study results for lead drug candidate

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Larimar Therapeutics reports ...
Yahoo

Bill Nye Reveals Family's Heartbreaking Health Battle (EXCLUSIVE)

Children all over the country grew up watching Bill Nye the Science Guy explain a variety of scientific terms to them. And now, the 69-year-old is ready to do so again. In a recent sitdown with ...
The Business Journals

National Ataxia Foundation teams up with Bill Nye for educational series on rare disorder

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min National celebrity Bill Nye ...